Article: New migraine drugs promise relief — but at a steep price

Specific Illnesses & Conditions VM/MAV
1

Monoclonal antibodies are apparently the next big thing.

http://www.theverge.com/2016/5/24/11712554/migraine-drug-treatment-headache-cost-pharmaceutical-health-insurance

2

Goodness. Relief for the rich only? I suspect the price will fall over time though? And presumably its usefullness for MAV in particular will have to be proven separately to regular migraine?